Study of Microcirculation of Patients with Varicose Veins of Lower Limbs

Abstract

Varicose veins of lower limbs have always caused, because of their rate, highest social spendings. Those patients who have trophic disturbances often need surgical treatment even after surgical intervention. This condition becomes worse in Southern Europe countries because of environmental and climatic factors.

INTRODUCTION

Varicose veins of lower limbs have always caused, because of their rate,highest social spendings. Those patients
who have trophic disturbances often need surgical treatment even after surgical intervention. This condition becomes worse in Southern Europe countries because of
environmental and climatic factors.
It is therefore necessary to improve diagnostic methods in order to prevent trophic disturbances.
In order to reach this target, our Institute studies all patients affected by varicose disease not only by doppler
c.w. but also by microcirculatory methods, such as Videocapillaroscopy and Reflected Light Rheography on medial malleolus.

MATERIALS AND METHODS

Thirty patients (24 females and 4 males) suffering from varicose veins of lower limbs at 2nd or 3rd stage of Widmer
classification, were studied by Reflected Light Rheography and Videocapillaroscopy on medial malleolus of both legs.
In order to avoid any interference, capillaroscopy was ever made before RLR; in the same way, no drugs during the
period of study were administered. In the patients with only one affected leg, the other leg gave useful comparison parameters.

RESULTS

In the group of 30 patients the following parameters were evaluated: Venous network, refilling time (TO), venous drain capability (dr), capillaries density and morphology. About rheographic parameters we found TO equal to 12+-3 seconds and dr equal to 100+-50 mV (mean values). In the group of patients at 2nd Widmer stage, TO was equal to 16+-3 seconds and dr was equal to the patients at 3d Widmer stage TO respectively, equal to 8+-2 seconds About capillaroscopic parameters, capillaries density in all subjects; formation” pictures, espectively, (13,3%) patients.

CONCLUSIONS

The study of microcirculation by Capillaroscopy and Rheography, in the patients suffering from varicose veins of lower limbs, was with no doubt useful to demonstrate that any stage of venous disorders causes different microcirculatory alterations. In fact, we found “”halo formation· pictures in patients with more pathological rheographic parameters (TO less than 10 seconds) and nearly all these patients suffered from varicose disease at 3rd stage of Widmer classification. Furthermore, microcirculatory alterations were more evident in patients with trophic disturbances and elder venous disease.

Reference: https://link.springer.com/chapter/10.1007/978-1-4471-3095-6_50

HOW D’OXYVA CAN HELP?

D’OXYVA is the only fully noninvasive, completely painless transdermal (over-the-skin) microcirculatory solution that has been clinically tested to significantly improve microcirculation.

The improvement of microcirculation, i.e., blood flow to the smallest blood vessels, benefits one’s health, immune system and overall sense of well-being in a variety of ways.

LEARN MORE ABOUT D’OXYVA

Reduce Unwanted Doctor Visits, Recommended & Ranked Top by Experts

Our editorial team consists of professional writers, internationally-renowned medical doctors, scientists, regulatory experts, and business executives.

physician-recommended, easy to use daily

Why Use D'OXYVA?

World-renowned health experts say D’OXYVA® can help patients find relief especially from the most severe and complex underlying conditions in a few weeks. According to overwhelming medical data, people with preexisting conditions, including diabetes, autoimmune, and cardiovascular complications could greatly benefit from improved microcirculation, tissue perfusion, and autonomic nervous system functions.

D’OXYVA significantly helps people and their pets by gently and quickly spraying a patented and patent-pending ultra-purified, supersaturated solution on the skin surface to achieve major health benefits for well over 90% of users. Experts call D’OXYVA a game-changer biotech.

Studies with D’OXYVA have shown unmatched results in noninvasive wound care. Anyone with an underlying condition should know this option is available.

Dr. Michael McGlamry